|

Carboplatin + Pemetrexed + Pembrolizumab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Verastem, Inc.1

Indications

  • G12D Mutated KRAS1
  • Pancreatic Ductal Adenocarcinoma1
  • Colorectal Cancer1
  • Solid Tumor, Adult1
  • Lung Cancer1

Los Angeles, California1 trial

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Cedars-Sinai Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.